Found 16 results

Name Type of Offering Accepted Date
SRKP 16 INC See All Filings
D/A 2012-04-05
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-12-000076
Exclusions or Exemptions N/A
Accepted Date 2012-04-05
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D 2015-01-02
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-15-000002
Exclusions or Exemptions 506b
Accepted Date 2015-01-02
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
SRKP 16 INC See All Filings
D 2012-01-23
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-12-000016
Exclusions or Exemptions N/A
Accepted Date 2012-01-23
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D/A 2013-03-06
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-13-000035
Exclusions or Exemptions N/A
Accepted Date 2013-03-06
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
SRKP 16 INC See All Filings
D 2012-01-23
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-12-000017
Exclusions or Exemptions N/A
Accepted Date 2012-01-23
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D/A 2012-12-20
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-13-000003
Exclusions or Exemptions N/A
Accepted Date 2012-12-20
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D 2018-05-08 13:41:47
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-18-000041
Exclusions or Exemptions 506b
Accepted Date 2018-05-08 13:41:47
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
SRKP 16 INC See All Filings
D/A 2012-07-17
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-12-000147
Exclusions or Exemptions N/A
Accepted Date 2012-07-17
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D 2014-03-07
Amount To Be Raised $700,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-14-000034
Exclusions or Exemptions 506b
Accepted Date 2014-03-07
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
ARROGENE, INC See All Filings
D 2016-03-18
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-16-000143
Exclusions or Exemptions 506b
Accepted Date 2016-03-18
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
ARROGENE, INC See All Filings
D 2019-10-30 13:25:32
Amount To Be Raised $990,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-19-000041
Exclusions or Exemptions 506b
Accepted Date 2019-10-30 13:25:32
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
SRKP 16 INC See All Filings
D/A 2012-02-13
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-12-000037
Exclusions or Exemptions N/A
Accepted Date 2012-02-13
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D/A 2012-12-20
Amount To Be Raised $4,800,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-13-000002
Exclusions or Exemptions N/A
Accepted Date 2012-12-20
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
ARROGENE, INC See All Filings
D/A 2014-04-04
Amount To Be Raised $700,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-14-000055
Exclusions or Exemptions 506b
Accepted Date 2014-04-04
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
ARROGENE, INC See All Filings
D/A 2014-05-05
Amount To Be Raised $700,000
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-14-000074
Exclusions or Exemptions 506b
Accepted Date 2014-05-05
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
ARROGENE, INC See All Filings
D 2018-03-14 12:16:02
Amount To Be Raised $2,755,458
Associated Brokers / Dealers N/A
CIK Number 0001403792
Filed Document 0001011034-18-000026
Exclusions or Exemptions 506b
Accepted Date 2018-03-14 12:16:02
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity